Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Diseases: From Mechanistic Insights to Biomarkers

Phase I/II clinical trials of autologous hematopoietic stem cell transplantation (AHSCT) have led to increased safety and efficacy of this therapy for severe and refractory autoimmune diseases (AD). Recent phase III randomized studies have demonstrated that AHSCT induces long-term disease remission...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Immunol
Main Authors: Malmegrim, Kelen Cristina Ribeiro, Lima-Júnior, João Rodrigues, Arruda, Lucas Coelho Marlière, de Azevedo, Júlia Teixeira Cottas, de Oliveira, Gislane Lelis Vilela, Oliveira, Maria Carolina
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2018
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6250746/
https://ncbi.nlm.nih.gov/pubmed/30505303
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.02602
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados